Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SYNGAP1 Antikörper (AA 1185-1199)

Der Kaninchen Polyklonal Anti-SYNGAP1-Antikörper wurde für WB, IF und IHC validiert. Er ist geeignet, SYNGAP1 in Proben von Ratte zu detektieren.
Produktnummer ABIN7043789

Kurzübersicht für SYNGAP1 Antikörper (AA 1185-1199) (ABIN7043789)

Target

Alle SYNGAP1 Antikörper anzeigen
SYNGAP1 (Synaptic Ras GTPase Activating Protein 1 (SYNGAP1))

Reaktivität

  • 19
  • 10
  • 8
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Ratte

Wirt

  • 18
  • 2
Kaninchen

Klonalität

  • 16
  • 4
Polyklonal

Konjugat

  • 17
  • 1
  • 1
  • 1
Dieser SYNGAP1 Antikörper ist unkonjugiert

Applikation

  • 16
  • 11
  • 5
  • 5
  • 4
  • 3
  • 2
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1185-1199

    Verwendungszweck

    A Rabbit Polyclonal Antibody to SynGAP

    Spezifität

    C-terminus

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Mouse,human - identical

    Produktmerkmale

    Anti-SynGAP Antibody (ABIN7043789, ABIN7045176 and ABIN7045177) is a highly selective antibody directed against an epitope of the rat protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize SynGAP from human, mouse, and rat samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)KSMDESRLDRVKEYE, corresponding to amino acid residues 1185-1199 of rat SynGAP

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:200

    Application Dilutions Western blot wb: 1:400

    Kommentare

    Negative Control: (ABIN7237319)

    Blocking Peptide: (ABIN7237319)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    0.2 mL double distilled water (DDW).

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    SYNGAP1 (Synaptic Ras GTPase Activating Protein 1 (SYNGAP1))

    Andere Bezeichnung

    SYNGAP1

    Hintergrund

    SynGAP1, Synaptic Ras GTPase-activating protein 1, Synaptic Ras-GAP 1, Neuronal RasGAP, p135 SynGAP,SynGAP1 is a major signaling protein that plays a pivotal role in regulating fundamental molecular changes in dendritic spine synaptic morphological and functional modifications.SynGAP1 functions as a downstream component of NMDA receptor-associated signaling and of AMPA receptor trafficking to excitatory postsynaptic membrane. SynGAP1 is mainly expressed in the hippocampus and cortex.SynGAP1 is a cytosolic protein without a signal peptide or any transmembrane domain. The N-terminal half of SYNGAP1 has a Ras-GAP domain, along with the region that is loosely homologous to Pleckstrin homology and a C2 domain which is potentially involved in binding Ca2+ and phospholipids. Interestingly, the alignment of GAP domain of SynGAP1 with other Ras-GAPs suggests that the amino acids in the GAP domain are crucial for interacting with Ras and for stimulating Ras-GTPase activity. The C-terminal half consists of a repeat of 10 histidines that may be involved in metal chelation, several potential serine and tyrosine phosphorylation sites and a T/SXV motif necessary for interaction with SAP102 and PSD-95.SynGAP1 has been implicated in the pathogenesis of intellectual disability. de novo out-of-frame deletions were identified in patients with intellectual disability presenting with microcephaly and generalized epilepsy while de novo microdeletions in chromosome region 6p21.3 were observed in patients with severe language impairment in addition to epilepsy. SynGAP1 may also be involved in the pathogenesis of schizophrenia through altered regulation of the NMDA receptor complex.

    Alternative names: SynGAP, SynGAP1, Synaptic Ras GTPase-activating protein 1, Synaptic Ras-GAP 1, Neuronal RasGAP, p135 SynGAP

    Gen-ID

    192117

    NCBI Accession

    NM_006772

    UniProt

    Q9QUH6

    Pathways

    Regulation of long-term Neuronal Synaptic Plasticity
Sie sind hier:
Chat with us!